Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.
President, Novartis Institutes for BioMedical Research (NIBR)
Fiona H. Marshall, Ph.D.
President, Innovative Medicines International & Chief Commercial Officer